Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devalingam Mahalingam

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Journal of Surgical Oncology|October 4, 2022
Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinomaCasey M Silver, Rachel H Joung, Charles D Logan, et al.
Communications Medicine|January 13, 2024
First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumorsDevalingam Mahalingam, Wael Harb, Amita Patnaik, et al.
Journal of Hematology & Oncology|November 13, 2025
First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignanciesDaruka Mahadevan, Minal Barve, Devalingam Mahalingam, et al.
Oncotarget|June 19, 2023
Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancerDevalingam Mahalingam, Salih Hanni, Anthony V Serritella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2019
Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib StudyDevalingam Mahalingam, Grey A Wilkinson, Kevin H Eng, et al.
Blood|March 6, 2010
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemiaRonan T Swords, Kevin R Kelly, Peter G Smith, et al.
Journal of Cellular and Molecular Medicine|July 9, 2009
Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulationJennifer S Carew, Ernest C Medina, Juan A Esquivel, et al.
Autophagy|July 4, 2014
Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumorsDevalingam Mahalingam, Monica Mita, John Sarantopoulos, et al.
Cancers|July 2, 2021
Detection of Hepatocellular Carcinoma in a High-Risk Population by a Mass Spectrometry-Based TestDevalingam Mahalingam, Leonidas Chelis, Imran Nizamuddin, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2014
Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumorsDevalingam Mahalingam, John J Nemunaitis, Laeeq Malik, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Journal of Surgical Oncology|October 4, 2022
Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinomaCasey M Silver, Rachel H Joung, Charles D Logan, et al.
Communications Medicine|January 13, 2024
First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumorsDevalingam Mahalingam, Wael Harb, Amita Patnaik, et al.
Journal of Hematology & Oncology|November 13, 2025
First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignanciesDaruka Mahadevan, Minal Barve, Devalingam Mahalingam, et al.
Oncotarget|June 19, 2023
Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancerDevalingam Mahalingam, Salih Hanni, Anthony V Serritella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2019
Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib StudyDevalingam Mahalingam, Grey A Wilkinson, Kevin H Eng, et al.
Blood|March 6, 2010
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemiaRonan T Swords, Kevin R Kelly, Peter G Smith, et al.
Journal of Cellular and Molecular Medicine|July 9, 2009
Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulationJennifer S Carew, Ernest C Medina, Juan A Esquivel, et al.
Autophagy|July 4, 2014
Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumorsDevalingam Mahalingam, Monica Mita, John Sarantopoulos, et al.
Cancers|July 2, 2021
Detection of Hepatocellular Carcinoma in a High-Risk Population by a Mass Spectrometry-Based TestDevalingam Mahalingam, Leonidas Chelis, Imran Nizamuddin, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2014
Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumorsDevalingam Mahalingam, John J Nemunaitis, Laeeq Malik, et al.
Pageof 11